Focus on Machinery of Cell Death
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: 15 December 2025 | Viewed by 8164
Special Issue Editors
Interests: cancer; autophagy; apoptosis; cell biology; biochemistry; metabolism; therapy
Interests: autophagy; cancer; metabolism; apoptosis; stem cell biology
Special Issue Information
Dear Colleagues,
This Special Issue of Cells will be devoted to exploring the ever-evolving field of the different molecular mechanisms of cell death during development, diseases, and infection. The focus will be on the cross-talk between different types of cell death induction, including apoptosis, autophagy-associated cell death, necrosis, stem cell biology, metabolism, ageing, neurodegeneration, cancer, and infection-associated diseases, to name a few. We are also welcoming papers that highlight different therapeutic methods of cell death induction, particularly those relevant to the treatment of the mentioned situations.
Papers on the different types of death during mammalian cell demise following the recommendations of the Nomenclature Committee on Cell Death (2018) are encouraged. This Special Issue will also cover how the cell death process undergoes developmental transformation and how this makes us more vulnerable with time. On that note, the different dietary and life style changes that can help us ensure a better life will be emphasized, by focusing on the role of antioxidant redox biology in cell death and development.
We hope that this Special Issue will provide a very interesting platform to learn new developments from bench to bedside therapies by enhancing our knowledge around cell death mechanism pathways. Both original research articles and reviews are welcome.
Dr. Subhadip Mukhopadhyay
Dr. Prashanta Kumar Panda
Dr. Suprabhat Mukherjee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cell death
- autophagy
- apoptosis
- necrosis
- ferroptosis
- metabolism
- stem cell biology
- infection
- aging
- development
- Alzheimer’s
- neurodegeneration
- therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Novel Insights into the Mechanisms of Pro-Apoptotic TRAIL Receptor Activation
Authors: Law,Brian K.; Law,Mary Elizabeth
Affiliation: 1
Abstract: TNF-related apoptosis-inducing ligand/Apo-2 ligand (TRAIL) was discovered long ago to selectively induce apoptosis of cancer cells through Death Receptors 4 and 5 (DR4/5), while sparing normal tissue. Despite the important role of TRAIL in anti-cancer immunity and metastasis suppression, and the safety of TRAIL analogs and agonistic antibodies, agents targeting the TRAIL/TRAIL receptor pathway have shown insufficient anti-cancer efficacy in unstratified patients in clinical trials. This review briefly outlines the TRAIL/TRAIL receptor pro-apoptotic signaling pathway, cross-species differences in TRAIL signaling, mechanisms of TRAIL resistance, and pharmacological liabilities of TRAIL analogs and TRAIL receptor agonistic antibodies. The remainder of the review focuses on 1) the mechanisms responsible for TRAIL selectivity for cancer cells, 2) the recent discovery of and mechanistic insights into an extracellular DR5 auto-inhibitory domain, and 3) how the new conceptual model for DR5 activation may a) explain how DR5 functions as a direct receptor for misfolded proteins, b) predict the anti-cancer efficacy of DR5 agonist antibodies, and c) reveal differential disulfide bonding as a molecular “switch” between active and inactive DR5 conformations.